Molgramostim Terminated Phase 2 Trials for Mycobacterium Infections, Nontuberculous / Cystic Fibrosis (CF) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03597347Trial of Inhaled Molgramostim in CF Subjects With NTM Infection